Quarterly Financial Data (Unaudited) (Detail Narrative) (USD $)	3 Months Ended								12 Months Ended
	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Quarterly Financial Information Disclosure [Abstract]
Benefit (expense) recorded representing changes in accounts receivable allowance	$ (100,000)	$ 0	$ 0	$ 100,000	$ 200,000	$ 200,000	$ (300,000)	$ 600,000
Gain on sale of cost-method investment	1,900,000								2,096,364	0	0
Restructuring charges	$ 1,300,000								$ 3,606,020	$ 770,749	$ 822,320